Thrombotic microangiopathies
- 1 June 2014
- journal article
- review article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 43 (6) , 797-805
Abstract
No abstract availableKeywords
This publication has 132 references indexed in Scilit:
- Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiencyTransfusion, 2011
- Mutations in Complement Regulatory Proteins Predispose to Preeclampsia: A Genetic Analysis of the PROMISSE CohortPLOS Medicine, 2011
- Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndromeBlood, 2010
- Mutations in complement C3 predispose to development of atypical hemolytic uremic syndromeBlood, 2008
- Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpuraBlood, 2008
- Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndromeBlood, 2008
- Two Mechanistic Pathways for Thienopyridine-Associated Thrombotic Thrombocytopenic PurpuraJACC, 2007
- Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndromeProceedings of the National Academy of Sciences, 2007
- Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcomeBlood, 2006
- Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient miceProceedings of the National Academy of Sciences, 2006